Journal
Therapeutic Advances in Hematology
Publication Date
1-1-2022
Volume
13
First Page
20406207221088458
Document Type
Open Access Publication
DOI
10.1177/20406207221088458
Rights and Permissions
Dimopoulos MA, Mikhael J, Terpos E, Leleu X, Moreau P, Bladé J, Kim JS, Stockerl-Goldstein K, Richardson PG. An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment. Ther Adv Hematol. 2022 Apr 2;13:20406207221088458. doi.org/10.1177/20406207221088458 © The Author(s), 2022. Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Recommended Citation
Dimopoulos, Meletios A; Mikhael, Joseph; Terpos, Evangelos; Leleu, Xavier; Moreau, Philippe; Bladé, Joan; Kim, Jin Seok; Stockerl-Goldstein, Keith; and Richardson, Paul G, "An overview of treatment options for patients with relapsed/refractory multiple myeloma and renal impairment." Therapeutic Advances in Hematology. 13, 20406207221088458 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11693
